Comparative analysis of Lebanon development. Prospects for cooperation with the Russian Federation
- 作者: El Moussawi M.1,2, Mironenkova Z.1, Umarov S.1, Knysh O.3, Nemyatykh O.1
-
隶属关系:
- Saint-Petersburg State Chemical and Pharmaceutical University
- ”Mohammed” Pharmacy
- Tyumen State Medical University
- 期: 卷 8, 编号 3 (2020)
- 页面: 205-218
- 栏目: Articles
- URL: https://journals.rcsi.science/2307-9266/article/view/111646
- DOI: https://doi.org/10.19163/2307-9266-2020-8-3-205-218
- ID: 111646
如何引用文章
详细
The objective of the research was to conduct a comparative analysis of the development of Lebanon based on a number of demographic, economic and social indicators characterizing the health care of Lebanon, and to determine the prospects for the cooperation with the Russian Federation (RF) in the pharmacy field.
Materials and methods. The studies were conducted from 2009 to 2016. The objects were the statistical data accumulated on the basis of the data from national institutions and international organizations. These data were published annually in the reports of the Department of Economic and Social Affairs, the United Nations Population Division for 11 countries in the Middle East: Bahrain, Jordan, Yemen, Kuwait, Lebanon, United Arab Emirates, Oman, Saudi Arabia (Asian countries); Egypt, Sudan, Tunisia (North African countries). The research methods were: a comparative analysis, analytical grouping of data, ranking.
Results and discussion. A comparative analysis of demographic, economic and social indicators revealed that low mortality rates and high life expectancy in Lebanon were achieved both due to a satisfactory level of health care financing (Rank 5) and due to the adoption of adequate decisions in organizing and managing the Lebanese health care system. The positive trends that were inherent in the Lebanese health care system in previous decades continued to operate within the framework of earlier inertia, while migration flows intensified. However, there has been a slowdown in the decline in infant mortality in the dynamics of growth rates, which is a signal of the emergence of negative processes in the social sphere of the country.
Conclusion. The current situation in the Lebanese health care system, associated with limited financial resources, poses new challenges in the search for managerial decisions in the field of organizational management. The import of drugs from the Russian Federation will provide a significant reduction in the financial costs of providing the population of Lebanon and migrants with medicines which will increase the monetary costs of providing medical care.
作者简介
Mohamad El Moussawi
Saint-Petersburg State Chemical and Pharmaceutical University; ”Mohammed” Pharmacy
编辑信件的主要联系方式.
Email: drmohamadmoussawi@hotmail.com
ORCID iD: 0000-0001-5432-7680
candidate of the Department of medical and pharmaceutical commodity science; the head of the Pharmacy
俄罗斯联邦, 14, Bld. A, Prof. Popov St., St Petersburg, 197376; 12, Hadath, Beirut, Lebanon 90201Zhanna Mironenkova
Saint-Petersburg State Chemical and Pharmaceutical University
Email: shanna.mironenkova@pharminnotech.com
ORCID iD: 0000-0003-1029-093X
Doctor of Sciences (Pharmacy), Associate Professor, Professor of the Department of medical and pharmaceutical commodity science
俄罗斯联邦, 14, Bld. A, Prof. Popov St., St Petersburg, 197376Sergey Umarov
Saint-Petersburg State Chemical and Pharmaceutical University
Email: sergei.umarov@pharminnotech.com
ORCID iD: 0000-0003-0771-6143
Doctor of Sciences (Pharmacy), Professor, the Head of the Department of Medical and Pharmaceutical Commodity Science
俄罗斯联邦, 14, Bld. A, Prof. Popov St., St Petersburg, 197376Olga Knysh
Tyumen State Medical University
Email: knysho@mail.ru
ORCID iD: 0000-0001-6150-1683
Doctor of Sciences (Pharmacy), Professor, the Head of the Department of Pharmaceutical Disciplines
俄罗斯联邦, 54, Odessa St., Tyumen, 625023Oksana Nemyatykh
Saint-Petersburg State Chemical and Pharmaceutical University
Email: oksana.nemyatyh@pharminnotech.com
ORCID iD: 0000-0001-5933-2120
Doctor of Sciences (Pharmacy), Professor, Professor of the Department of Pharmacy Management and Economics
俄罗斯联邦, 14, Bld. A, Prof. Popov St., St Petersburg, 197376参考
- Ledov, DG, Bogdanov Yu. Migration crisis in Lebanon. Humanitarian scientific research. 2016; 9(61):188–190.
- Ammar W, Kdouh O, Hammoud R, Hamadeh R, Harb H, Ammar Z, Atun R, Christiani D, Zalloua PA. Health system resilience: Lebanon and the Syrian refugee crisis. J Glob Health. 2016;6(2):020704. doi: 10.7189/jogh.06.020704.
- Fotoeva AV. The Main article of individual manufacturers as a component of drug safety pages. Bulletin Of Roszdravnadzor. 2017;5:55–58.
- Trofimova, EO, Denisova MN. Russian pharmaceutical market: position of domestic companies. Pharmacy. 2018; 67(1):3–7. doi: 10.29296/25419218-2018-01-01.
- Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices –budget impact analysis. Value Health. 2007;10(5):336–47. doi: 10.1111/j.1524-4733.2007.00187.x.
- Marchenko YuO. Improving the competitiveness of Russian companies in the global pharmaceutical market based on the use of import substitution tools. Fundamental and applied research: problems and results. 2015; 21:173–187.
- Sazava NN. The current state, conditions and prospects of development of world pharmaceutical market. Russian foreign economic Bulletin.2015;12:118–129.
- Trofimova, EO. Macroeconomic factors and financing of the healthcare system as prerequisites for the development of the pharmaceutical market. Remedium. Magazine about the Russian market of medicines and medical equipment. 2017;S13:22–34.
- Lin, AA, Sokolova SV, Golant ZM. Pharmaceutical market: a model for supporting the export of medicines. Problems of the modern economy. 2016;1 (57):162–166.
- Esangina, IA, Yushkov ES. analysis of the current state of the pharmaceutical market of Russia. Economic research and development: scientific research electronic journal. Nizhny Novgorod: NOO «Professional science». 2018;6:91–97.
- Bahlol, MM, Lagutkina TP. Analysis of scientific research on the promotion of pharmaceutical products in foreign countries: practical recommendations for pharmaceutical companies. Bulletin of Siberian medicine. 2016;15(1):60–68. doi: 10.20538/1682-0363-2016-1-60-68.
- Sapir EV, Karachev IA Features of the world pharmaceutical market and problems of its development by Russian companies. Russian foreign economic Bulletin. 2016;8:97–111.
- Andreeva EL, Sapir EV, Karkh DA, Karachev IA. Comparative analysis of foreign economic development of the pharmaceutical sector in the Russian Federation and the USA. Regional Economy. 2019;15(2):576–589. DOI 10.17059 / 2019-2-20.
- Demidenok DA, Petrova TA, Narkevich IA, Markova VA. Trends in the global pharmaceutical market: unrealized development opportunities. Development and registration of medicines. 2017;4(21):282–287.
- Filatova, YuM, Romanova LV, Larikova II. Current state of the world pharmaceutical market. Proceedings of the Tula state University. The Economic Series.2016;2:167–174.
- Sapir EV, Karachev IA, Zhang M. Export potential of Russian pharmaceutical enterprises in emerging regional clusters. Regional economy.2016;12(4):1194–1204.
- Mironenkova ZhV, Moussawi ME, Davletyanova AF. Main characteristics of ART in HIV-infected citizens of the Lebanese Republic. Journal of Infectology.2017; 9(3):109–116. DOI: 10.22625 / 2072-6732-2017-9-3-109-116.
- Karachev IA. Development of the Russian pharmaceutical market at the present stage. Bulletin of the Samara state University of Economics. 2016; 8(142):71–77.
- Ryzhova, OA, Moroz TL. Results of the analysis of import substitution of antitumor drugs in the Russian Federation for 2013-2018. Pharmacy and pharmacology.2019;7(2):105–111. doi: 10.19163/2307-9266-2019-7-2-105-111.
补充文件
